After sales service very competent, responsive and pleasant.
Extract from the guestbook quesionnaire
The European Respiratory Society (ERS), organized its 29th congress from 28 September to 02 October 2019 in Madrid, Spain. Showcasing the excellence of respiratory medicine, it is an essential event for all pneumology professionals and the patient associations concerned. It brings together more than 15,000 doctors, scientists and other specialists in respiratory medicine (research laboratories, etc.).
This event promotes scientific research and provides access to educational resources on diseases such as asthma, the heart of the Optimhal-Protecsom laboratory.
The Optimhal-Protecsom laboratory actively participated in this knowledge sharing by presenting its latest research on several inhalation chambers for mechanical ventilation circuits, including Combihaler.
Combihaler® is an inhalation chamber for mechanical ventilation systems. It allows for the simultaneous administration of metered-dose drugs and a mesh nebulizer.
In this study, the in vitro performances of several spacers, including CombiHaler®, were evaluated for drug delivery with pressurized metered dose inhaler (pMDI) and vibrating mesh nebulizer, in comparison with T adapters usually used, in an adult mechanical ventilation model.
Results showed that in vitro drug delivery is higher when using a spacer instead of T pieces, with both a pMDI and a vibrating mesh nebulizer.
CombiHaler has similar or higher in vitro performances than other spacers and permits the use of both a pMDI and a vibrating mesh nebulizer without dismantling the breathing circuit : these are new successful results which strengthen our goals and our purpose of continuous improvement.
Each year, the Optimhal-Protecsom laboratory invests more than 25% of its turnover in research. This is an essential point for designing tomorrow’s medical devices with a constant goal : to improve the quality of life of patients and facilitate the work of caregivers.
In autumn, all the conditions are met to promote the proliferation of dust mites: heated housing, less airy, closed windows and reduced light are all factors that contribute to the concentration of allergenic particles in your indoor environment.
More than 3 in 10 French people suffer from allergy to dust mites and many people ignore it or minimize its consequences.
Among the 35% of French people who say they are allergic, 1 in 2 people considers that it is not a “real” disease and is thus exposed to a sometimes very serious evolution of their allergic disease. Asthma has an allergic origin for 80% of children and 50% of adults.
Respiratory illness is not to be taken lightly!
The association Asthme & Allergies calls, through an information and awareness campaign, patients and parents of allergic children to mobilize to better and faster detect allergy to dust mites in order to avoid these evolutions to asthma or other severe pathologies.
The Protecsom Laboratory, a specialist in allergen protection and improvement of the quality of life of patients, actively participates in this new awareness campaign of the association Asthma & Allergies, with several other partners and actors in the fight against mite allergy.
A 100% digital campaign !
This awareness campaign is deployed in the media and on social networks.
Discover four videos that feature the different symptoms of mite allergy (Eternity, Difficult Awakening, Runny Nose, etc.) and a page to answer all questions related to mite allergy. (Symptoms, Solutions and Risks).
A game created by the association Asthma & Allergy may also allow you to gain your protection. Be vigilant !
Emma Blondel obtained, Sunday, June 2, 2019, the departmental and regional gold medal of the contest “Un des Meilleurs Apprentis de France” in the ready-to-wear category.
This competition, organized by the “Société Nationale des Meilleurs Ouvriers de France”, is intended for young people under 21 years in initial training or apprenticeship contract, represents the excellence of know-how in more than 200 trades.
A prestigious award that recognizes the motivation, investment and work quality of Emma, a young apprentice in the Laboratoire OptimHal-ProtecSom. And it’s not over ! With this victory Emma will extend the pleasure by participating in the national contest.
Back on her story and passion for fashion :
Emma: “Already a little girl, I had fun customizing the clothes of my Barbies. It really was a trigger and that’s how I showed an interest in the fashion business.”
Then Emma decided to choose a training in connection with her passion: A bachelor’s degree “Métiers de la Mode Vêtement” at the Thomas Pesquet high school in Coutances. She is doing her alternating training in the Laboratoire OptimHal-ProtecSom which has provided this young apprentice an environment conducive to the success of its various projects.
Emma: “During my second year of training, I participated in my first competition: Fashion in Normandy. I realized the technical part of a garment, research part before its conception (choice of the tissues, range of assembly…). This first contest allowed me to consolidate my professional project : to work in a design office and method, to be the link between production and offices. “
Emma: “I was supported and encouraged by my professors and colleagues from the Laboratoire OptimHal-ProtecSom”.
Emma : “We had the choice between 3 projects : ready-to-wear, fuzzy clothes or tailor. I preferred the ready-to-wear theme in which we had to make a dress, subject to specials requirements. For 3 months, I designed step by step the dress and its technical file.”
Emma : “This medal is very rewarding for my work. I hope this award will help me in my future career.”
Emma : “After graduating, there are many ways to consider the futur : look for work or go to school. I decided to carry on my studies by integrating a “BTS Métier de la Mode” to get more skills that will allow me to integrate a design office and method.
OptimHal-ProtecSom laboratory participated to the new edition of the “Respiratory Drug Delivery” Congress holding in Estoril’s Convention Center in Lisbon, Portugal, from May 7th to 10. This congress is one of the most important international event dealing with drug delivery system by respiratory route.
Research team of laboratory OptimHal-ProtecSom was here with a rich and varied program: expositions, sessions, workshop…
OptimHal-ProtecSom laboratory invests every year more than 25% of its income in its research center. This contribution is essential to offer our team the means to imagine and create medical devices for the future which improves the quality of life to the patients and the work of medical staff.
Every medical device in our laboratory are subject to various scientific studies to validate their efficiency. This year, three studies had been submitted to the “Respiratory Drug Delivery” congress.
Throughout the congress, Edouard CURRAN, PhD, R&D project manager at laboratoire OptimHal-ProtecSom, presented a poster about DigitHal® probe. In this study, an instantaneous, accurate and reproducible measurement of the patient’s respiratory flow was performed by the probe during the valved holding chamber use. The impact of the probe on the drug delivery has also been studied and no change in the efficiency of the valved holding chamber was detected.
With these information, DigitHal® probe could be used as a learning tool which improving technique to the patient.
The importance of developing such help devices was exposed a long time during the session 5 of the congress : “ Re-inventing Inhalers for the Digital Age”.
Doctor (PhD) Myriam ECKES, project manager R&D in OptimHal-ProtecSom laboratory, exposes two posters about mechanical ventilation studies.
The first one deals with the In Vitro performances of CombiHaler® spacer. Dedicated for mechanical ventilation system, CombiHaler® allows the use, without disassembling of the circuit, of a pMDI and a vibrating mesh nebulizer.
The aim of this study was to evaluate the effect of the volume of CombiHaler® spacer on the administration of drugs by mechanical ventilation.
The results shows that the volume has a strong influence when inhalation chamber is placed before the Y piece and less when it’s placed after.
MinimHal® is an inhalation chamber with small volume for use in mechanical ventilation breathing system.
Its low volume allows a use for paediatric patients and at different locations on the mechanical ventilation circuit.
The aim of this study was to evaluate the in vitro performance of MinimHal® in a mechanical ventilation circuit.